Cargando…
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) have a similar clinical phenotype but represent distinct diseases, requiring different therapies. MicroRNAs (miRNAs) are short non-coding RNAs whose expression profiles can serve as diagnostic biomarkers and which...
Autores principales: | Keller, Andreas, Leidinger, Petra, Meese, Eckart, Haas, Jan, Backes, Christina, Rasche, Ludwig, Behrens, Janina R., Pfuhl, Catherina, Wakonig, Katharina, Gieß, René M., Jarius, Sven, Meder, Benjamin, Bellmann-Strobl, Judith, Paul, Friedemann, Pache, Florence C., Ruprecht, Klemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628234/ https://www.ncbi.nlm.nih.gov/pubmed/26521232 http://dx.doi.org/10.1186/s12974-015-0418-1 |
Ejemplares similares
-
Olfactory Dysfunction in Patients with Neuromyelitis Optica
por: Schmidt, Felix, et al.
Publicado: (2013) -
Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019) -
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
por: Rasche, Ludwig, et al.
Publicado: (2016) -
Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
por: Gieß, René M., et al.
Publicado: (2017) -
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)